Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5′-monophosphate in COPD

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 3 PART I, 1998, Pages 880-886

  Rutgers, Steven R ^a   Koëter, Gerard H ^a   Van Der Mark, Thomas W ^a   Postma, Dirkje S ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; BUDESONIDE; CYCLIC AMP; INTERLEUKIN 8; IPRATROPIUM BROMIDE; METHACHOLINE; PLACEBO; TERBUTALINE; TERFENADINE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DOSE RESPONSE; FORCED EXPIRATORY VOLUME; HUMAN; HYPOTHESIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT PLANNING;

ADENOSINE MONOPHOSPHATE; ADMINISTRATION, INHALATION; ANTI-INFLAMMATORY AGENTS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTOR AGENTS; BRONCHODILATOR AGENTS; BUDESONIDE; CHOLINERGIC ANTAGONISTS; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; INTERLEUKIN-8; IPRATROPIUM; LEUKOCYTE COUNT; LONGITUDINAL STUDIES; LUNG DISEASES, OBSTRUCTIVE; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; NEUTROPHILS; PLACEBOS; SMOKING; TERFENADINE; TIME FACTORS;

EID: 0031898901     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.3.9709100     Document Type: Article

References (32)

1. Siafakas, N. M., P. Vermeire, N. B. Pride, P. Paoletti, J. Gibson, P. Howard, J. C. Yernault, M. Decramer, T. Higenbottam, D. S. Postmaa, and J. Reece. 1995. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): The European Respiratory Society Task Force. Eur. Respir. J. 8:1398-1420.
2. American Thoracic Society (Official statement). 1996. Cigarette smoking and health. Am. J. Respir. Crit. Care Med. 153:861-865.
3. 1: The Lung Health Study. J.A.M.A. 272:1497-1505.
4. Thompson, W. H., C. P. Nielson, P. Carvalho, N. B. Charan, and J. J. Crowley. 1996. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am. J. Respir. Crit. Care Med. 154:407-412.
5. Djukanovic, R., J. W. Wilson, K. M. Britten, S. J. Wilson, A. F. Walls, W. R. Roche, P. H. Howarth, and S. T. Holgate. 1992. The effect of an inhaled corticosteroid on airway inflammation and symptoms of asthma Am. Rev. Respir. Dis. 145:669-674.
6. Kraan, J., G. H. Koëter, T. W. v. d. Mark, H. J. Sluiter, and K. De Vries. 1985. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J. Allergy Clin. Immunol. 76:628-636.
7. Oosterhoff, Y., G. H. Koëter, J. G. De Monchy, and D. S. Postma. 1993. Circadian variation in airway responsiveness to methacholine, propranolol, and AMP in atopic asthmatic subjects. Am. Rev. Respir. Dis. 147:512-517.
8. Weersink, E. J. M., W. R. Douma, D. S. Postma, and G. H. Koëter. 1997. Fluticasone propionate, salmeterol xinafoate, and their combination: treatment of nocturnal asthma. Am. J. Respir. Crit. Care Med. 155:1241-1246.
9. Auffarth, B. K., D. S. Postma, J. G. R. De Monchy, T. W. Van der Mark, M. Boorsma, and G. H. Koëter. 1991. Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease. Thorax 46:372-377.
10. Thompson, A. B., M. B. Mueller, A. J. Heires, T. L. Bohling, D. Daughton, S. W. Yancey, R. S. Sykes, and S. I. Rennard. 1992. Aerosolized beclomethasone in chronic bronchitis: improved pulmonary function and diminished airway inflammation. Am. Rev. Respir. Dis. 146:389-395.
11. Weir, D. C., and P. S. Burge. 1993. Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction. Thorax 48:309-316.
12. Seatta, M. P., A. Di Stefano, P. Maestrelli, A. Ferraresso, R. Drigo, A. Potena, A. Ciaccia, and L. M. Fabbri. 1993. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am. Rev. Respir. Dis. 147:301-306.
13. Thompson, A. B., D. Daughton, R. A. Robbins, M. A. Ghafouri, M. Oehlerking, and S. I. Rennard. 1989. Intraluminal airway inflammation in chronic bronchitis: characterization and correlation with clinical parameters. Am. Rev. Respir. Dis. 140:1527-1537.
14. Pesci, A., G. A. Rossi, G. Bertorelli, A. Aufiero, P. Zanon, and D. Olivieri. 1994. Mast cells in the airway lumen and bronchial mucosa of patients with chronic bronchitis. Am. J. Respir. Crit. Care Med. 149:1311-1316.
15. Turnbull, L. W., L. S. Turnbull, J. Crofton, and A. B. Kay. 1978. Variations in chemical mediators of hypersensitivity in the sputum of chronic bronchitics: correlation with peak expiratory flow. Lancet 2:184-186.
16. Postma, D. S., J. J. Keyzer, G. H. Koëter, H. J. Sluiter, and K. De Vries. 1985. Influence of the parasympathetic and sympathetic nervous system on nocturnal bronchial obstruction. Clin. Sci. 69:251-258.
17. Phillips, G. D., P. Rafferty, R. Beasley, and S. T. Holgate. 1987. Effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5′-monophosphate in non-atopic asthma. Thorax 42:939-945.
18. Polosa, R., G. D. Phillips, K. Rajakulasingam, and S. T. Holgate. 1991. The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5′-monophosphate and histamine in asthma. J. Allergy Clin. Immunol. 87:939-947.
19. American Thoracic Society. 1987. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136:225-244.
20. Quanjer, P. H., G. J. Tammeling, J. E. Cotes, O. F. Pedersen, R. Peslin, and J.-C. Yernault. 1993. Lung volumes and forced ventilatory flows. Eur. Respir. J. 6:5-40.
21. Juniper, E. F., P. A. Frith, C. Dunnett, D. W. Cockcroft, and F. E. Hargreave. 1978. Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 33:705-710.
22. Jeffery, P. K. 1994. Comparative morphology of the airways in asthma and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 150:S6-S13.
23. Lacoste, J. Y. L., J. Bousquet, P. Chanez, T. Van Vyve, J. Simony-Lafontaine, N. Lequeu, P. Vic, I. Enander, P. Godard, and F.-B. Michel. 1993. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J. Allergy Clin. Inimunol. 92:537-548.
24. Keatings, V., A. Jatakanon, Y. Miin Worsdell, and P. J. Barnes. 1997. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am. J. Respir. Crit. Care Med. 155:542-548.
25. Kerstjens, H. A., P. L. Brand, M. D. Hughes, N. J. Robinson, D. S. Postma, H. J. Sluiter, E. R. Bleecker, P. N. Dekhuijzen, P. M. de Jong, H. J. Mengelers, S. E. Overbeek, and D. F. Schoonbrood. 1992. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease: Dutch Chronic Non-Specific Lung Disease Study Group. N. Engl. J. Med. 327:1413-1419.
26. Oosterhoff, Y., J. W. de Jong, M. A. M. Jansen, G. H. Koëter, and D. S. Postma. 1993. Airway responsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease is determined by smoking. Am. Rev. Respir. Dis. 147:553-558.
27. Dompeling, E., C. P. van Schayck, P. M. van Grunsven, C. L. van Herwaarden, R. Akkermans, J. Molema, H. Folgering, and C. van Weel. 1993. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids: a 4-year prospective study. Ann. Intern. Med. 118:770-778.
28. Smith, W. B., J. R. Gamble, I. Clark Lewis, and M. A. Vadas. 1991. Interleukin-8 induces neutrophil transendothelial migration. Immunology 72:65-72.
29. Mocker, R. E., D. F. Schoonbrood, E. A. van de Graaf, C. E. Hack, R. Lutter, H. M. Jansen, and T. A. Out. 1996. Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. Int. Arch. Allergy Immunol. 109:183-191.
30. Chanez, P., I. Enander, I. Jones, P. Godard, and J. Bousquet. 1996. Interleukin-8 in bronchoalveolar lavage of asthmatic and chronic bronchitis patients. Int. Arch. Allergy Immunol. 111:83-88.
31. Baggiolini, M., A. Walz, and S. L. Kunkel. 1989. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84:1045-1049.
32. Marquardt, D. L., H. J. Motulsky, and S. I. Wasserman. 1982. Rat lung cholinergic receptor: characterization and regulation by corticosteroids. J. Appl. Physiol. 53:731-736.